Original text
European Commission - Press release Commission announces new global health commitments at One Health Summit Lyon, 7 April 2026 The European Commission intends to pledge €700 million to the Global Fund to defeat HIV, tuberculosis and malaria. It will also invest €46.5 million to strengthen health security in Africa and Europe with a focus on tackling antimicrobial resistance (AMR), and €50 million in research and deve...
European Commission - Press release Commission announces new global health commitments at One Health Summit Lyon, 7 April 2026 The European Commission intends to pledge €700 million to the Global Fund to defeat HIV, tuberculosis and malaria. It will also invest €46.5 million to strengthen health security in Africa and Europe with a focus on tackling antimicrobial resistance (AMR), and €50 million in research and development for AMR and neglected tropical diseases. Commissioner for International Partnerships, Jozef Síkela , made these announcements at the One Health Summit taking place today in Lyon, France. They underline the European Union's continued leadership in global health and its commitment to strengthening the resilience of health systems worldwide. The announcements are within the scope of the new Global Health Resilience Initiative, announced by President von der Leyen in the 2025 State of the Union address and which is expected to be launched before the summer. The initiative will offer the opportunity to clearly set out EU priorities and define concrete avenues for effective and efficient action on Global Health. €700 million to the Global Fund's 8th replenishment The Commission intends to pledge €700 million overall for the 8th replenishment of the Global Fund , with €185 million immediately available under the current long-term budget. The country-level grants resulting from the 8th replenishment will be implemented from 2027 to 2029. The Global Fund is a worldwide partnership to defeat HIV, tuberculosis and malaria, which has saved millions of lives and significantly reduced mortality from the three diseases while investing in resilient and sustainable health systems and global health security. It focuses in particular on the most vulnerable populations at risk, especially women and girls who often face barriers to accessing lifesaving health services. Team Europe, comprising the Commission and the EU Member States, remains among the strongest supporters of the Global Fund, with a total pledge of more than €3 billion for the 8th replenishment. Since the Global Fund's creation in 2002, Team Europe contributions represent around one third of all donor contributions. New EU programmes worth €46.5 million on One Health cooperation and the response to AMR EU investments of €46.5 million will help consolidate the African health security architecture and foster partnerships between European and African stakeholders, strengthening the One Health workforce and the response to AMR. The funding will support AMR surveillance, prevention and control at national, regional and continental levels, strengthen laboratory capacity and diagnostics across Africa, and increase cooperation between European and African health agencies over the next five years. The implementation will be done together with key partners including the European Centre for Disease Prevention and Control, the Africa Centres for Disease Control and Prevention, the European Food Safety Authority, the European and Developing Countries Clinical Trials Partnership and the International Centre for Antimicrobial Resistance Solutions. Antimicrobial resistance is one of the most serious global health threats. If no action is taken, by 2050 it is projected to cause up to 10 million deaths annually, of which 4.5 million would be in Africa. AMR is already associated with more than 35 000 deaths annually in Europe, and costs European healthcare systems an estimated €11 billion each year. New R&D investments of €50 million in AMR and neglected tropical diseases The European Commission will make a €30 million investment to support the development of new antibiotics and medical countermeasures against AMR. The funding, managed by KfW, Germany's Development Bank, will support the not-for-profit organisations Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) and the Global Antibiotic Research & Development Partnership (GARDP) to accelerate early-stage antibacterial research and to advance late-stage clinical development projects, ensuring a diversified and continuous pipeline for AMR medical countermeasures. To further advance protection against global health threats, the Commission had signed a €20 million contribution agreement with the Agence Française de Développement (AFD) for the implementation of activities by the non-profit research organisation Drugs for Neglected Diseases initiative (DNDi), in support of the development of dengue medical treatments . This project was launched in March in anticipation of increasing needs for medical countermeasures against vector- borne diseases in the EU driven by climate change. Background The European Union's commitment to global health is set out in the EU Global Health Strategy adopted in 2022 and in the Global Gateway strategy, which identifies health as a key investment priority. The EU's global health engagement focuses on strengthening health systems, improving health security, supporting local manufacturing of health products, and advancing universal health coverage, especially in partner countries in Sub-Saharan Africa. The EU participation in the One Health Summit is a milestone towards the upcoming Global Health Resilience Initiative, which will seek to deliver lasting impact for populations worldwide. A public consultation on the initiative is currently open until 13 April. For More Information EU global health resilience initiative Health and demography - International Partnerships Health - International Partnerships Health Emergency Preparedness and Response (HERA) IP/26/776 Quote(s): "Global health security is a shared responsibility and a strategic investment in our common future. With our support to the Global Fund and our new One Health initiative with Africa, the European Union confirms its commitment to strengthening health systems and global health resilience. The EU remains a reliable partner committed to international cooperation and long-term investment in global health through Global Gateway." Jozef Síkela, Commissioner for International Partnerships "With this action, the Commission, through its Health Emergency Preparedness and Response Authority (HERA), is strengthening EU preparedness by supporting innovation for antibacterial products and other countermeasures against antimicrobial resistance (AMR). By aligning innovation from early discovery through to clinical validation, we can accelerate the development of these lifesaving products and ensure their availability. This approach tackles AMR and strengthens EU readiness for future health threats." Hadja Lahbib, Commissioner for Equality, Preparedness and Crisis Management Press contacts: Guillaume MERCIER (+32 2 29 80564) Anna-Kaisa ITKONEN (+32 2 29 57501) General public inquiries: Europe Direct by phone 00 800 67 89 10 11 or by email
Speech Brief